Genprex, Inc. Contracts & Agreements
111 Contracts & Agreements
- Business Finance (52 contracts)
- Business Operations (7)
- Human Resources (22)
- Intellectual Property (11)
- Uncategorized (19)
- First Amendment to Executive Employment Agreement, dated as of June 24, 2024, by and between Genprex, Inc. and Ryan M. Confer (Filed With SEC on June 24, 2024)
- Separation Agreement and Release, dated as of June 21, 2024, by and between Genprex, Inc. and Catherine Vaczy (Filed With SEC on June 24, 2024)
- Genprex, Inc. Amended and Restated Outside Director Compensation Policy, adopted June 18, 2024 (Filed With SEC on June 24, 2024)
- Description of Registrant (Filed With SEC on April 1, 2024)
- Genprex, Inc. 2018 Equity Incentive Plan, dated April 3, 2018, including Forms of Award Agreements thereunder (Filed With SEC on April 1, 2024)
- Genprex, Inc. Form of Inducement Grant (Filed With SEC on April 1, 2024)
- Second Amendment to Exclusive License Agreement, dated November 3, 2022, by and between Genprex, Inc. and the University of Pittsburgh - Of the Commonwealth System of Higher... (Filed With SEC on April 1, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 20, 2024)
- Form of Warrant (Filed With SEC on March 20, 2024)
- Form of Placement Agent Warrant (Filed With SEC on March 20, 2024)
- Form of Warrant Amendment Agreement (Filed With SEC on March 20, 2024)
- Form of Purchase Agreement (Filed With SEC on March 20, 2024)
- At The Market Offering Agreement, dated December 13, 2023, by and between Genprex, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 13, 2023)
- Form of Warrant (Filed With SEC on July 19, 2023)
- Form of Placement Agent Warrant (Filed With SEC on July 19, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on July 19, 2023)
- Exclusive License Agreement, dated July 14, 2023 (Filed With SEC on July 18, 2023)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on June 27, 2023)
- Description of Registrant's Securities (Filed With SEC on March 31, 2023)
- Form of Warrant (Filed With SEC on February 27, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on February 27, 2023)
- Exclusive License Agreement, dated December 29, 2022 (Filed With SEC on January 5, 2023)
- Exclusive License Agreement, dated November 22, 2022 (Filed With SEC on November 28, 2022)
- Equity Distribution Agreement, dated November 18, 2022 by and among Genprex, Inc. and JMP Securities LLC (Filed With SEC on November 18, 2022)
- First Amendment to Exclusive License Agreement, dated August 17, 2022 (Filed With SEC on August 22, 2022)
- Form of Indemnity Agreement by and between the Company and its directors and officers, dated as of May 17, 2022 (Filed With SEC on August 12, 2022)
- Warrant Agreement with Bear Creek Capital, LLC, dated as of July 1, 2022 (Filed With SEC on August 12, 2022)
- Description of Registrant's Securities (Filed With SEC on March 30, 2022)
- Form of Warrant Agreement, dated as of July 1, 2021 (Filed With SEC on November 15, 2021)
- Offer Letter between Genprex, Inc. and Mark S. Berger, M.D (Filed With SEC on September 28, 2021)
- Option Award Agreement between Genprex, Inc. and Mark S. Berger, M.D. dated September 27, 2021 (Filed With SEC on September 28, 2021)
- Offer Letter between Genprex, Inc. and Hemant Kumar, PhD (Filed With SEC on September 28, 2021)
- Option Award Agreement between Genprex, Inc. and Hemant Kumar, PhD dated September 27, 2021 (Filed With SEC on September 28, 2021)
- Form of Warrant Agreement, dated as of February 10, 2021 (Filed With SEC on May 17, 2021)
- Warrant Agreement, dated August 10, 2020, issued to Capital City Technical Consulting, Inc (Filed With SEC on March 26, 2021)
- Amended and Restated Warrant Agreement, dated August 10, 2020, issued to DABS Advanced Biotech Solutions, LLC (Filed With SEC on March 26, 2021)
- Amended and Restated Warrant Agreement, dated August 10, 2020, issued to DABS Advanced Biotech Solutions, LLC (Filed With SEC on March 26, 2021)
- Description of Registrant's Securities (Filed With SEC on March 26, 2021)
- Amendment No. 1 to Patent and Technology License Agreement, dated March 3, 2021, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center (Filed With SEC on March 26, 2021)
- First Amendment to Executive Employment Agreement dated as of March 24, 2021 by and between Genprex, Inc. and Catherine Vaczy (Filed With SEC on March 25, 2021)
- First Amendment to Executive Employment Agreement dated as of March 24, 2021 by and between Genprex, Inc. and Michael Redman (Filed With SEC on March 25, 2021)
- Placement Agency Agreement dated February 8, 2021 (Filed With SEC on February 9, 2021)
- Form of Securities Purchase Agreement dated February 8, 2021 (Filed With SEC on February 9, 2021)
- Placement Agency Agreement dated December 22, 2020 (Filed With SEC on December 23, 2020)
- Form of Securities Purchase Agreement dated December 22, 2020 (Filed With SEC on December 23, 2020)
- Warrant Agreement, dated as of August 10, 2020, by and between Genprex, Inc. and Capital City Technical Consulting, Inc (Filed With SEC on November 12, 2020)
- Patent and Technology License Agreement dated as of May 4, 2020, by and between Genprex, Inc. and The Board of Regents of The University of Texas System (Filed With SEC on May 14, 2020)
- Warrant Agreement dated as of April 24, 2020, by and between Genprex, Inc. and Cancer Revolution LLC (Filed With SEC on April 28, 2020)
- Separation Agreement dated as of April 27, 2020, by and between Genprex, Inc. and Julien L Pham, MD, MPH (Filed With SEC on April 28, 2020)
- Description of Registrant's Securities (Filed With SEC on March 30, 2020)
- Amendment No. 1 to Stock Option Agreement dated as of March 18, 2020, by and between Genprex, Inc. and David E. Friedman (Filed With SEC on March 24, 2020)
- Amendment No. 1 to Stock Option Agreement dated as of March 18, 2020, by and between Genprex, Inc. and Robert W. Pearson (Filed With SEC on March 24, 2020)
- Executive Employment Agreement dated as of March 12, 2020, by and between Genprex, Inc. and Catherine M. Vaczy (Filed With SEC on March 23, 2020)
- Executive Employment Agreement dated as of March 12, 2020, by and between Genprex, Inc. and Michael T. Redman (Filed With SEC on March 23, 2020)
- Placement Agency Agreement dated February 19, 2020 (Filed With SEC on February 20, 2020)
- Form of Securities Purchase Agreement dated February 19, 2020 (Filed With SEC on February 20, 2020)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on February 18, 2020)
- Placement Agency Agreement dated January 23, 2020 (Filed With SEC on January 24, 2020)
- Form of Securities Purchase Agreement dated January 23, 2020 (Filed With SEC on January 24, 2020)
- Form of Securities Purchase Agreement dated January 16, 2020 (Filed With SEC on January 17, 2020)
- Form of Securities Purchase Agreement dated November 20, 2019 (Filed With SEC on November 22, 2019)
- Form of Warrant (Filed With SEC on November 22, 2019)
- Outside Director Compensation Policy (Filed With SEC on November 8, 2018)
- Consulting Agreement with Viet Ly dated April 19, 2018 (Filed With SEC on August 14, 2018)
- Warrant Agreement dated July 27, 2018, issued to Cancer Revolution LLC (Filed With SEC on August 6, 2018)
- Warrant Agreement dated July 27, 2018, issued to Inception Capital Management, LLC (Filed With SEC on August 6, 2018)
- Warrant Agreement dated July 27, 2018, issued to Cancer Biotech LLC (Filed With SEC on August 6, 2018)
- Amended and Restated Executive Employment Agreement (Filed With SEC on May 30, 2018)
- Form of Warrant (Filed With SEC on May 10, 2018)
- Securities Purchase Agreement dated as of May 6, 2018, between Genprex, Inc. and the purchasers named on the signature pages thereto (Filed With SEC on May 10, 2018)
- Form of Registration Rights Agreement (Filed With SEC on May 10, 2018)
- Genprex, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on April 17, 2018)
- Genprex, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on April 17, 2018)
- Executive Employment Agreement dated April 13, 2018, by and between the Registrant and Rodney Varner (Filed With SEC on April 17, 2018)
- Executive Employment Agreement dated April 13, 2018, by and between the Registrant and Ryan Confer (Filed With SEC on April 17, 2018)
- Promissory Note (Filed With SEC on April 4, 2018)
- Promissory Note (Filed With SEC on March 15, 2018)
- Master Service Agreement (Filed With SEC on March 15, 2018)
- Promissory Note (Filed With SEC on December 14, 2017)
- Form of Underwriting Agreement (Filed With SEC on October 10, 2017)
- Form of Underwriters Warrant Agreement (Filed With SEC on October 10, 2017)
- Form of Amended and Restated Escrow Deposit Agreement by and among the Registrant, Signature Bank and the Underwriter (Filed With SEC on September 22, 2017)
- Form of Subscription Agreement (Filed With SEC on September 22, 2017)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on September 15, 2017)
- Form of Underwriters Warrant Agreement (Filed With SEC on September 15, 2017)
- Clinical Study Agreement dated February 10, 2014, by and between The University of Texas M.D. Anderson Cancer Center and the Registrant (Filed With SEC on September 15, 2017)
- Amendment No. 1 to Clinical Study Agreement dated June 25, 2015 (Filed With SEC on September 15, 2017)
- Form of Subscription Agreement (Filed With SEC on September 15, 2017)
- Form of Underwriting Agreement (Filed With SEC on September 8, 2017)
- Form of Indemnity Agreement by and between the Registrant and its directors and officers (Filed With SEC on September 8, 2017)
- Form of Genprex, Inc. 2017 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on September 8, 2017)
- Form of Genprex, Inc. 2017 Employee Stock Purchase Plan (Filed With SEC on September 8, 2017)
- Form of Genprex, Inc. Non-Employee Director Compensation Policy (Filed With SEC on September 8, 2017)
- Form of Escrow Deposit Agreement by and among the Registrant, Signature Bank and the Underwriter (Filed With SEC on September 8, 2017)
- Form of Executive Employment Agreement by and between the Registrant and Rodney Varner (Filed With SEC on September 8, 2017)
- Form of Executive Employment Agreement by and between the Registrant and Ryan Confer (Filed With SEC on September 8, 2017)
- TEXAS EMERGING TECHNOLOGY FUND AWARD AND SECURITY AGREEMENT BETWEEN THE STATE OF TEXAS AND CONVERGENLIFESCIENCES, INC. (Filed With SEC on August 18, 2017)
- CONVERGEN LIFESCIENCES, INC. INVESTMENT UNIT (Filed With SEC on August 18, 2017)
- GENPREX, INC. WARRANT AGREEMENT Effective as of December 17, 2015 (Filed With SEC on August 18, 2017)
- GENPREX, INC. WARRANT AGREEMENT Effective as of December 17, 2015 (Filed With SEC on August 18, 2017)
- GENPREX, INC. WARRANT AGREEMENT November 3, 2016 (Filed With SEC on August 18, 2017)
- CONVERGEN LIFECIENCES, INC. 2009 EQUITY INCENTIVE PLAN (Filed With SEC on August 18, 2017)
- PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on August 18, 2017)
- AMENDMENT NO. 3 TO PATENT AND TECHNOLOGY LICENSE AGREEMENT DATED JULY 31,1994 (Filed With SEC on August 18, 2017)
- TECHNOLOGY SUBLICENSE AGREEMENT (Filed With SEC on August 18, 2017)
- ASSIGNMENT AND COLLABORATION AGREEMENT (Filed With SEC on August 18, 2017)
- TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on August 18, 2017)
- AGREEMENT Between CONVERGEN LIFESCIENCES, INC. And THE UNIVERSITY OFTEXAS M. D. ANDERSON CANCER CENTER (Filed With SEC on August 18, 2017)
- TECHNOLOGY SUBLICENSE AGREEMENT (Filed With SEC on August 18, 2017)
- AMENDED COLLABORATION AND ASSIGNMENT AGREEMENT (Filed With SEC on August 18, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 18, 2017)
